株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

欧州の整形外科用バイオマテリアル市場の分析

Orthopedic Biomaterials Market | Europe | 2019-2025 | MedSuite (Includes 4 Repoorts)

発行 iData Research Inc. 商品コード 601886
出版日 ページ情報 英文 525 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=110.56円で換算しております。

※ Single Userライセンスは、DRM (デジタル著作権管理システム) 付PDFになります。
認証されたPC上のみでの閲覧となっております。

Back to Top
欧州の整形外科用バイオマテリアル市場の分析 Orthopedic Biomaterials Market | Europe | 2019-2025 | MedSuite (Includes 4 Repoorts)
出版日: 2019年05月02日 ページ情報: 英文 525 Pages
概要

当レポートでは、欧州諸国の整形外科用バイオマテリアルの市場について分析し、市場の背景事情や基本構造、全体的な市場動向の見通し (販売量・収益額・平均価格、市場成長率など、過去4年間・今後7年間分)、カテゴリー別の詳細動向、主な市場促進・抑制要因、昨今の市場情勢 (資本取引ほか)、主要企業のプロファイル、といった情報を取りまとめてお届けいたします。

エグゼクティブ・サマリー

欧州の整形外科用バイオマテリアル市場:概要

競争分析

市場の傾向

市場の発展

処置件数

分析対象市場

主要レポートの更新状況

過去のバージョン

分析手法

  • IDATAの9段階の分析方法

製品評価

  • 製品ポートフォリオ
  • 規制上の問題とリコール:分野別
  • 治験の状況:分野別・企業別

欧州の整形外科用バイオマテリアル市場の概要

  • イントロダクション
  • 為替レート
  • 市場概要
  • 部門別の動向分析
  • 市場促進・抑制要因
  • 企業別市場シェアの分析
  • 企業合併・買収 (M&A)
  • 企業プロファイル
    • Anika Therapeutics
    • Bioventus
    • DePuy Synthes
    • Ferring Pharmaceuticals
    • Fidia Pharmaceuticals
    • Genzyme (Sanofi Group)
    • Harvest Technologies (Terumo BCT)
    • Integra LifeSciences
    • Medtronic
    • Musculoskeletal Transplant Foundation (MTF)
    • NuVasive
    • Orthofix
    • RTI Surgical
    • Stryker
    • Vericel Corporation (旧:Aastrom Bioscience)
    • Zimmer Biomet
  • SWOT分析:主要企業の場合

各国のプロファイル

  • イントロダクション
    • 総人口
    • 1人当たりGDP
    • 価格指数
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • スペイン
  • ベネルクス諸国
  • 北欧諸国
  • オーストリア
  • スイス
  • ポルトガル

処置件数

  • イントロダクション
  • 処置の概要
    • 材料別・症状別
    • 処置1件当たり移植片数:症状別
  • 骨成長因子の処置件数:種類別
  • ヒアルロン酸補充療法の処置件数:種類別
  • 軟骨再建の処置件数:種類別

整形外科用代替骨移植片市場

  • イントロダクション
  • 市場概要:材料別、症状別
  • 市場の分析と予測
    • 代替骨移植片市場全体
    • 同種骨移植片市場
      • 脊椎用 (頚椎、胸腰椎)
      • 外傷治療・再建用
      • 頭蓋顎顔面(CMF)用
    • 合成骨移植片市場
    • 脱灰骨基質 (DBM) 同種移植片市場
  • 市場促進・抑制要因
  • 企業別市場シェアの分析

ヒアルロン酸関節内補充療法

  • イントロダクション
  • 市場概要
  • 市場分析・予測
    • ヒアルロン酸 (HA) 関節内補充療法の市場全体
    • 単回投与製品市場
    • 三回投与製品市場
    • 五回投与製品市場
  • 市場促進・抑制要因
  • 企業別の市場シェア分析

骨形成タンパク質増殖因子市場

  • イントロダクション
  • 市場分析・予測
  • 市場促進・抑制要因
  • 企業別の市場シェア分析

整形外科用軟骨修復市場

  • イントロダクション
  • 市場概要
  • 市場分析・予測
    • 骨軟変性同種移植片市場
    • 半月板同種移植片市場
    • 軟骨細胞自家移植片市場
    • 軟骨変性自家移植片市場
  • 市場促進・抑制要因
  • 企業別の市場シェア分析

付録I:整形外科用細胞療法市場

  • イントロダクション
  • 細胞療法の処置件数
    • 種類別の概況
  • 市場概要
  • 市場分析・予測
    • 多血小板血漿 (PPP) の市場全体
    • 骨髄濃縮物の市場全体
  • 市場促進・抑制要因
  • 企業別の市場シェア分析

付録II:自家細胞移植片市場

  • イントロダクション
    • 系統
      • ヒト胚性幹細胞 (hESC)
      • 間葉系幹細胞 (MSC)
      • その他の治療用途

略語一覧

図表

LIST OF CHARTS

  • Chart 1 1: Orthopedic Biomaterials Market by Segment, Europe, 2018 2
  • Chart 1 2: Orthopedic Biomaterials Market Overview, Europe, 2018 & 2025 2
  • Chart 3 1: Orthopedic Biomaterials Market by Segment, Europe, 2015 - 2025 105
  • Chart 3 2: Orthopedic Biomaterials Market Breakdown, Europe, 2018 106
  • Chart 3 3: Orthopedic Biomaterials Market Breakdown, Europe, 2025 107
  • Chart 3 4: Growth Rates by Segment, Orthopedic Biomaterials Market, Europe, 2015 - 2025 111
  • Chart 3 5: Leading Competitors, Orthopedic Biomaterials Market, Europe, 2018 120
  • Chart 4 1: Country Profile, Germany, 2018 161
  • Chart 4 2: Country Profile, France, 2018 162
  • Chart 4 3: Country Profile, United Kingdom, 2018 163
  • Chart 4 4: Country Profile, Italy, 2018 164
  • Chart 4 5: Country Profile, Spain, 2018 165
  • Chart 4 6: Country Profile, Benelux, 2018 166
  • Chart 4 7: Country Profile, Scandinavia, 2018 167
  • Chart 4 8: Country Profile, Austria, 2018 168
  • Chart 4 9: Country Profile, Switzerland, 2018 169
  • Chart 4 10: Country Profile, Portugal, 2018 170
  • Chart 5 1: Bone Graft Substitute Procedure Numbers by Material, Europe, 2015 - 2025 175
  • Chart 5 2: Bone Graft Substitute Procedure Numbers by Indication, Europe, 2015 - 2025 178
  • Chart 5 3: Growth Factor Bone Graft Procedure Numbers, Europe, 2015 - 2025 183
  • Chart 5 4: Hyaluronic Acid Treatment Numbers by Type, Europe, 2015 - 2025 187
  • Chart 5 5: Cartilage Repair Procedure Numbers by Type, Europe, 2015 - 2025 191
  • Chart 6 1: Bone Graft Substitute Market by Material, Europe, 2015 - 2025 196
  • Chart 6 2: Bone Graft Substitute Market Breakdown by Material, Europe, 2018 197
  • Chart 6 3: Bone Graft Substitute Market Breakdown by Material, Europe, 2025 198
  • Chart 6 4: Bone Graft Substitute Market by Indication, Europe, 2015 - 2025 202
  • Chart 6 5: Bone Graft Substitute Market Breakdown by Indication, Europe, 2018 203
  • Chart 6 6: Bone Graft Substitute Market Breakdown by Indication, Europe, 2025 204
  • Chart 6 7: Total Bone Graft Substitute Market, Europe, 2015 - 2025 206
  • Chart 6 8: Total Allograft Market by Segment, Europe, 2015 - 2025 215
  • Chart 6 9: Total Allograft Market, Europe, 2015 - 2025 217
  • Chart 6 10: Total Allograft Spine Market by Segment, Europe, 2015 - 2025 225
  • Chart 6 11: Total Allograft Spine Market, Europe, 2015 - 2025 227
  • Chart 6 12: Allograft Cervical Spine Market, Europe, 2015 - 2025 234
  • Chart 6 13: Allograft Thoracolumbar Spine Market, Europe, 2015 - 2025 241
  • Chart 6 14: Allograft Trauma and Reconstruction Market, Europe, 2015 - 2025 248
  • Chart 6 15: Allograft Craniomaxillofacial Market, Europe, 2015 - 2025 255
  • Chart 6 16: Total Synthetic Market by Segment, Europe, 2015 - 2025 264
  • Chart 6 17: Total Synthetic Market, Europe, 2015 - 2025 266
  • Chart 6 18: Total Synthetic Spine Market by Segment, Europe, 2015 - 2025 274
  • Chart 6 19: Total Synthetic Spine Market, Europe, 2015 - 2025 276
  • Chart 6 20: Synthetic Cervical Spine Market, Europe, 2015 - 2025 283
  • Chart 6 21: Synthetic Thoracolumbar Spine Market, Europe, 2015 - 2025 290
  • Chart 6 22: Synthetic Trauma and Reconstruction Market, Europe, 2015 - 2025 297
  • Chart 6 23: Synthetic Craniomaxillofacial Market, Europe, 2015 - 2025 304
  • Chart 6 24: Total Demineralized Bone Matrix Market by Segment, Europe, 2015 - 2025 313
  • Chart 6 25: Total Demineralized Bone Matrix Market, Europe, 2015 - 2025 315
  • Chart 6 26: Total Demineralized Bone Matrix Spine Market by Segment, Europe, 2015 - 2025 323
  • Chart 6 27: Total Demineralized Bone Matrix Spine Market, Europe, 2015 - 2025 325
  • Chart 6 28: Demineralized Bone Matrix Cervical Spine Market, Europe, 2015 - 2025 332
  • Chart 6 29: Demineralized Bone Matrix Thoracolumbar Spine Market, Europe, 2015 - 2025 339
  • Chart 6 30: Demineralized Bone Matrix Trauma and Reconstruction Market, Europe, 2015 - 2025 346
  • Chart 6 31: Demineralized Bone Matrix Craniomaxillofacial Market, Europe, 2015 - 2025 353
  • Chart 6 32: Leading Competitors, Bone Graft Substitute Market, Europe, 2018 366
  • Chart 7 1: Hyaluronic Acid Viscosupplementation Market by Segment, Europe, 2015 - 2025 373
  • Chart 7 2: Hyaluronic Acid Viscosupplementation Market Breakdown, Europe, 2018 374
  • Chart 7 3: Hyaluronic Acid Viscosupplementation Market Breakdown, Europe, 2025 375
  • Chart 7 4: Total Hyaluronic Acid Viscosupplementation Market, Europe, 2015 - 2025 378
  • Chart 7 5: Single-Injection Market, Europe, 2015 - 2025 386
  • Chart 7 6: Three-Injection Market, Europe, 2015 - 2025 394
  • Chart 7 7: Five-Injection Market, Europe, 2015 - 2025 402
  • Chart 7 8: Leading Competitors, Hyaluronic Acid Viscosupplementation Market, Europe, 2018 415
  • Chart 8 1: Bone Morphogenetic Protein Growth Factor Therapy Market, Europe, 2015 - 2025 419
  • Chart 8 2: Leading Competitors, Bone Morphogenetic Protein Growth Factor Therapy Market, Europe, 2018 429
  • Chart 9 1: Cartilage Repair Market by Segment, Europe, 2015 - 2025 434
  • Chart 9 2: Cartilage Repair Market Breakdown, Europe, 2018 435
  • Chart 9 3: Cartilage Repair Market Breakdown, Europe, 2025 436
  • Chart 9 4: Osteochondral Allograft Market, Europe, 2015 - 2025 438
  • Chart 9 5: Meniscal Allograft Market, Europe, 2015 - 2025 440
  • Chart 9 6: Autologous Chondrocyte Implantation Market, Europe, 2015 - 2025 443
  • Chart 9 7: Osteochondral Autograft Market, Europe, 2015 - 2025 450
  • Chart 9 8: Leading Competitors, Cartilage Repair Market, Europe, 2018 455
  • Chart 10 1: Cell Therapy Treatment Numbers by Type, Europe, 2015 - 2025 462
  • Chart 10 2: Orthopedic Cell Therapy Market by Segment, Europe, 2015 - 2025 466
  • Chart 10 3: Orthopedic Cell Therapy Market Breakdown, Europe, 2018 467
  • Chart 10 4: Orthopedic Cell Therapy Market Breakdown, Europe, 2025 468
  • Chart 10 5: Platelet-Rich Plasma Market, Europe, 2015 - 2025 470
  • Chart 10 6: Bone Marrow Concentrate Market, Europe, 2015 - 2025 477
  • Chart 10 7: Leading Competitors, Orthopedic Cell Therapy Market, Europe, 2018 488

LIST OF FIGURES

  • Figure 1 1: Wound and Tissue Management Market Share Ranking by Segment, Europe, 2018 (1 of 2) 3
  • Figure 1 2: Wound and Tissue Management Market Share Ranking by Segment, Europe, 2018 (2 of 2) 4
  • Figure 1 3: Companies Researched in this Report (1 of 2) 5
  • Figure 1 4: Companies Researched in this Report (2 of 2) 6
  • Figure 1 5: Factors Impacting the Wound and Tissue Management Market by Segment, Europe (1 of 2) 7
  • Figure 1 6: Factors Impacting the Wound and Tissue Management Market by Segment, Europe (2 of 2) 8
  • Figure 1 7: Recent Events in the Wound and Tissue Management Market, 2015 - 2018 9
  • Figure 1 8: Wound and Tissue Management Markets Covered (1 of 2) 10
  • Figure 1 9: Wound and Tissue Management Markets Covered (2 of 2) 11
  • Figure 1 10: Key Report Updates 12
  • Figure 1 11: Version History 12
  • Figure 3 1: Wound Closure Devices Market by Company (1 of 2) 43
  • Figure 3 2: Wound Closure Devices Market by Company (2 of 2) 44
  • Figure 3 3: Traditional Wound Dressing Market by Company (1 of 2) 47
  • Figure 3 4: Traditional Wound Dressing Market by Company (2 of 2) 48
  • Figure 3 5: Advanced Wound Dressing Market by Company (1 of 6) 58
  • Figure 3 6: Advanced Wound Dressing Market by Company (2 of 6) 59
  • Figure 3 7: Advanced Wound Dressing Market by Company (3 of 6) 60
  • Figure 3 8: Advanced Wound Dressing Market by Company (4 of 6) 61
  • Figure 3 9: Advanced Wound Dressing Market by Company (5 of 6) 62
  • Figure 3 10: Advanced Wound Dressing Market by Company (6 of 6) 63
  • Figure 3 11: Surgical Hemostats Market by Company 67
  • Figure 3 12: Tissue Sealants Market by Company 70
  • Figure 3 13: Anti-Adhesion Market by Company 72
  • Figure 3 14: Negative Pressure Wound Therapy Market by Company 73
  • Figure 3 15: Static Compression Therapy Market by Company (1 of 2) 77
  • Figure 3 16: Static Compression Therapy Market by Company (2 of 2) 78
  • Figure 3 17: Dynamic Compression Therapy Market by Company (1 of 2) 81
  • Figure 3 18: Dynamic Compression Therapy Market by Company (2 of 2) 82
  • Figure 4 1: Currency Exchange Rate, 2018 185
  • Figure 4 2: Wound and Tissue Management Market by Segment, Europe, 2015 - 2025 (€M) (1 of 2) 187
  • Figure 4 3: Wound and Tissue Management Market by Segment, Europe, 2015 - 2025 (€M) (2 of 2) 188
  • Figure 4 4: Wound and Tissue Management Market by Segment, Europe, 2015 - 2025 (US$M) (1 of 2) 189
  • Figure 4 5: Wound and Tissue Management Market by Segment, Europe, 2015 - 2025 (US$M) (2 of 2) 190
  • Figure 4 6: Wound and Tissue Management Market Growth by Segment, Europe, 2015 - 2025 (1 of 2) 196
  • Figure 4 7: Wound and Tissue Management Market Growth by Segment, Europe, 2015 - 2025 (2 of 2) 197
  • Figure 4 8: Drivers and Limiters, Wound and Tissue Management Market, Europe, 2018 201
  • Figure 4 9: Leading Competitors, Wound and Tissue Management Market, Europe, 2018 (1 of 2) 206
  • Figure 4 10: Leading Competitors, Wound and Tissue Management Market, Europe, 2018 (2 of 2) 207
  • Figure 4 11: SWOT Analysis, 3M, 2018 (1 of 2) 237
  • Figure 4 12: SWOT Analysis, 3M, 2018 (2 of 2) 237
  • Figure 4 13: SWOT Analysis, Acelity, 2018 (1 of 2) 239
  • Figure 4 14: SWOT Analysis, Acelity, 2018 (2 of 2) 240
  • Figure 4 15: SWOT Analysis, Baxter, 2018 (1 of 2) 241
  • Figure 4 16: SWOT Analysis, Baxter, 2018 (2 of 2) 242
  • Figure 4 17: SWOT Analysis, BSN Medical, 2018 243
  • Figure 4 18: SWOT Analysis, C. R. Bard (Becton Dickinson), 2018 (1 of 2) 244
  • Figure 4 19: SWOT Analysis, C. R. Bard (Becton Dickinson), 2018 (2 of 2) 245
  • Figure 4 20: SWOT Analysis, Cardinal Health, 2018 (1 of 2) 246
  • Figure 4 21: SWOT Analysis, Cardinal Health, 2018 (2 of 2) 247
  • Figure 4 22: SWOT Analysis, CryoLife, 2018 248
  • Figure 4 23: SWOT Analysis, Ethicon, 2018 (1 of 2) 249
  • Figure 4 24: SWOT Analysis, Ethicon, 2018 (2 of 2) 250
  • Figure 4 25: SWOT Analysis, Medline, 2018 (1 of 2) 251
  • Figure 4 26: SWOT Analysis, Medline, 2018 (2 of 2) 252
  • Figure 4 27: SWOT Analysis, Medtronic, 2018 (1 of 2) 253
  • Figure 4 28: SWOT Analysis, Medtronic, 2018 (2 of 2) 254
  • Figure 4 29: SWOT Analysis, MiMedx, 2018 (1 of 2) 255
  • Figure 4 30: SWOT Analysis, MiMedx, 2018 (2 of 2) 256
  • Figure 4 31: SWOT Analysis, Molnlycke, 2018 257
  • Figure 4 32: SWOT Analysis, Pfizer, 2018 258
  • Figure 4 33: SWOT Analysis, Sanofi Genzyme, 2018 259
  • Figure 4 34: SWOT Analysis, Smith & Nephew, 2018 (1 of 2) 260
  • Figure 4 35: SWOT Analysis, Smith & Nephew, 2018 (2 of 2) 261
  • Figure 6 1: Wound Closure Market by Segment, Europe, 2015 - 2025 (€M) 278
  • Figure 6 2: Wound Closure Market by Segment, Europe, 2015 - 2025 (US$M) 279
  • Figure 6 3: Wound Closure Market Growth by Segment, Europe, 2015 - 2025 284
  • Figure 6 4: Drivers and Limiters, Wound Closure Market, Europe, 2018 288
  • Figure 6 5: Leading Competitors, Wound Closure Market, Europe, 2018 292
  • Figure 6 6: Leading Competitors, Cyanoacrylate-Based Tissue Adhesive Market, Europe, 2018 294
  • Figure 7 1: Suture Market by Segment, Europe, 2015 - 2025 (€M) 299
  • Figure 7 2: Suture Market by Segment, Europe, 2015 - 2025 (US$M) 299
  • Figure 7 3: Absorbable Suture Market, Europe, 2015 - 2025 304
  • Figure 7 4: Units Sold by Country, Absorbable Suture Market, Europe, 2015 - 2025 306
  • Figure 7 5: Average Selling Price by Country, Absorbable Suture Market, Europe, 2015 - 2025 (€) 307
  • Figure 7 6: Average Selling Price by Country, Absorbable Suture Market, Europe, 2015 - 2025 (US$) 308
  • Figure 7 7: Market Value by Country, Absorbable Suture Market, Europe, 2015 - 2025 (€M) 309
  • Figure 7 8: Market Value by Country, Absorbable Suture Market, Europe, 2015 - 2025 (US$M) 310
  • Figure 7 9: Non-Absorbable Suture Market by Segment, Europe, 2015 - 2025 (€M) 312
  • Figure 7 10: Non-Absorbable Suture Market by Segment, Europe, 2015 - 2025 (US$M) 313
  • Figure 7 11: Total Non-Absorbable Suture Market, Europe, 2015 - 2025 315
  • Figure 7 12: Units Sold by Country, Total Non-Absorbable Suture Market, Europe, 2015 - 2025 317
  • Figure 7 13: Average Selling Price by Country, Total Non-Absorbable Suture Market, Europe, 2015 - 2025 (€) 318
  • Figure 7 14: Average Selling Price by Country, Total Non-Absorbable Suture Market, Europe, 2015 - 2025 (US$) 319
  • Figure 7 15: Market Value by Country, Total Non-Absorbable Suture Market, Europe, 2015 - 2025 (€M) 320
  • Figure 7 16: Market Value by Country, Total Non-Absorbable Suture Market, Europe, 2015 - 2025 (US$M) 321
  • Figure 7 17: Polypropylene Suture Market, Europe, 2015 - 2025 322
  • Figure 7 18: Units Sold by Country, Polypropylene Suture Market, Europe, 2015 - 2025 324
  • Figure 7 19: Average Selling Price by Country, Polypropylene Suture Market, Europe, 2015 - 2025 (€) 325
  • Figure 7 20: Average Selling Price by Country, Polypropylene Suture Market, Europe, 2015 - 2025 (US$) 326
  • Figure 7 21: Market Value by Country, Polypropylene Suture Market, Europe, 2015 - 2025 (€M) 327
  • Figure 7 22: Market Value by Country, Polypropylene Suture Market, Europe, 2015 - 2025 (US$M) 328
  • Figure 7 23: Polyester Suture Market, Europe, 2015 - 2025 329
  • Figure 7 24: Units Sold by Country, Polyester Suture Market, Europe, 2015 - 2025 331
  • Figure 7 25: Average Selling Price by Country, Polyester Suture Market, Europe, 2015 - 2025 (€) 332
  • Figure 7 26: Average Selling Price by Country, Polyester Suture Market, Europe, 2015 - 2025 (US$) 333
  • Figure 7 27: Market Value by Country, Polyester Suture Market, Europe, 2015 - 2025 (€M) 334
  • Figure 7 28: Market Value by Country, Polyester Suture Market, Europe, 2015 - 2025 (US$M) 335
  • Figure 7 29: Polyamide Suture Market, Europe, 2015 - 2025 336
  • Figure 7 30: Units Sold by Country, Polyamide Suture Market, Europe, 2015 - 2025 338
  • Figure 7 31: Average Selling Price by Country, Polyamide Suture Market, Europe, 2015 - 2025 (€) 339
  • Figure 7 32: Average Selling Price by Country, Polyamide Suture Market, Europe, 2015 - 2025 (US$) 340
  • Figure 7 33: Market Value by Country, Polyamide Suture Market, Europe, 2015 - 2025 (€M) 341
  • Figure 7 34: Market Value by Country, Polyamide Suture Market, Europe, 2015 - 2025 (US$M) 342
  • Figure 7 35: Silk Suture Market, Europe, 2015 - 2025 343
  • Figure 7 36: Units Sold by Country, Silk Suture Market, Europe, 2015 - 2025 345
  • Figure 7 37: Average Selling Price by Country, Silk Suture Market, Europe, 2015 - 2025 (€) 346
  • Figure 7 38: Average Selling Price by Country, Silk Suture Market, Europe, 2015 - 2025 (US$) 347
  • Figure 7 39: Market Value by Country, Silk Suture Market, Europe, 2015 - 2025 (€M) 348
  • Figure 7 40: Market Value by Country, Silk Suture Market, Europe, 2015 - 2025 (US$M) 349
  • Figure 7 41: Stainless Steel Suture Market, Europe, 2015 - 2025 350
  • Figure 7 42: Units Sold by Country, Stainless Steel Suture Market, Europe, 2015 - 2025 352
  • Figure 7 43: Average Selling Price by Country, Stainless Steel Suture Market, Europe, 2015 - 2025 (€) 353
  • Figure 7 44: Average Selling Price by Country, Stainless Steel Suture Market, Europe, 2015 - 2025 (US$) 354
  • Figure 7 45: Market Value by Country, Stainless Steel Suture Market, Europe, 2015 - 2025 (€M) 355
  • Figure 7 46: Market Value by Country, Stainless Steel Suture Market, Europe, 2015 - 2025 (US$M) 356
  • Figure 7 47: Drivers and Limiters, Suture Market, Europe, 2018 358
  • Figure 7 48: Leading Competitors, Suture Market, Europe, 2018 360
  • Figure 7 49: Leading Competitors by Country, Suture Market, Europe, 2018 361
  • Figure 8 1: Stapler Market by Segment, Europe, 2015 - 2025 (€M) 365
  • Figure 8 2: Stapler Market by Segment, Europe, 2015 - 2025 (US$M) 365
  • Figure 8 3: Open Surgery Stapler Market by Segment, Europe, 2015 - 2025 (€M) 370
  • Figure 8 4: Open Surgery Stapler Market by Segment, Europe, 2015 - 2025 (US$M) 370
  • Figure 8 5: Open Surgery Firing Gun Market, Europe, 2015 - 2025 372
  • Figure 8 6: Units Sold by Country, Open Surgery Firing Gun Market, Europe, 2015 - 2025 374
  • Figure 8 7: Average Selling Price by Country, Open Surgery Firing Gun Market, Europe, 2015 - 2025 (€) 375
  • Figure 8 8: Average Selling Price by Country, Open Surgery Firing Gun Market, Europe, 2015 - 2025 (US$) 376
  • Figure 8 9: Market Value by Country, Open Surgery Firing Gun Market, Europe, 2015 - 2025 (€M) 377
  • Figure 8 10: Market Value by Country, Open Surgery Firing Gun Market, Europe, 2015 - 2025 (US$M) 378
  • Figure 8 11: Open Surgery Cartridge Market, Europe, 2015 - 2025 379
  • Figure 8 12: Units Sold by Country, Open Surgery Cartridge Market, Europe, 2015 - 2025 381
  • Figure 8 13: Average Selling Price by Country, Open Surgery Cartridge Market, Europe, 2015 - 2025 (€) 382
  • Figure 8 14: Average Selling Price by Country, Open Surgery Cartridge Market, Europe, 2015 - 2025 (US$) 383
  • Figure 8 15: Market Value by Country, Open Surgery Cartridge Market, Europe, 2015 - 2025 (€M) 384
  • Figure 8 16: Market Value by Country, Open Surgery Cartridge Market, Europe, 2015 - 2025 (US$M) 385
  • Figure 8 17: Laparoscopic Stapler Market by Segment, Europe, 2015 - 2025 (€M) 387
  • Figure 8 18: Laparoscopic Stapler Market by Segment, Europe, 2015 - 2025 (US$M) 387
  • Figure 8 19: Laparoscopic Firing Gun Market, Europe, 2015 - 2025 389
  • Figure 8 20: Units Sold by Country, Laparoscopic Firing Gun Market, Europe, 2015 - 2025 391
  • Figure 8 21: Average Selling Price by Country, Laparoscopic Firing Gun Market, Europe, 2015 - 2025 (€) 392
  • Figure 8 22: Average Selling Price by Country, Laparoscopic Firing Gun Market, Europe, 2015 - 2025 (US$) 393
  • Figure 8 23: Market Value by Country, Laparoscopic Firing Gun Market, Europe, 2015 - 2025 (€M) 394
  • Figure 8 24: Market Value by Country, Laparoscopic Firing Gun Market, Europe, 2015 - 2025 (US$M) 395
  • Figure 8 25: Laparoscopic Cartridge Market, Europe, 2015 - 2025 396
  • Figure 8 26: Units Sold by Country, Laparoscopic Cartridge Market, Europe, 2015 - 2025 398
  • Figure 8 27: Average Selling Price by Country, Laparoscopic Cartridge Market, Europe, 2015 - 2025 (€) 399
  • Figure 8 28: Average Selling Price by Country, Laparoscopic Cartridge Market, Europe, 2015 - 2025 (US$) 400
  • Figure 8 29: Market Value by Country, Laparoscopic Cartridge Market, Europe, 2015 - 2025 (€M) 401
  • Figure 8 30: Market Value by Country, Laparoscopic Cartridge Market, Europe, 2015 - 2025 (US$M) 402
  • Figure 8 31: Skin Stapler Market, Europe, 2015 - 2025 403
  • Figure 8 32: Units Sold by Country, Skin Stapler Market, Europe, 2015 - 2025 405
  • Figure 8 33: Average Selling Price by Country, Skin Stapler Market, Europe, 2015 - 2025 (€) 406
  • Figure 8 34: Average Selling Price by Country, Skin Stapler Market, Europe, 2015 - 2025 (US$) 407
  • Figure 8 35: Market Value by Country, Skin Stapler Market, Europe, 2015 - 2025 (€M) 408
  • Figure 8 36: Market Value by Country, Skin Stapler Market, Europe, 2015 - 2025 (US$M) 409
  • Figure 8 37: Drivers and Limiters, Stapler Market, Europe, 2018 412
  • Figure 8 38: Leading Competitors, Stapler Market, Europe, 2018 414
  • Figure 9 1: Ligating Clip Applier Market by Segment, Europe, 2015 - 2025 (€M) 419
  • Figure 9 2: Ligating Clip Applier Market by Segment, Europe, 2015 - 2025 (US$M) 419
  • Figure 9 3: Open Surgery Ligation Market, Europe, 2015 - 2025 424
  • Figure 9 4: Units Sold by Country, Open Surgery Ligation Market, Europe, 2015 - 2025 426
  • Figure 9 5: Average Selling Price by Country, Open Surgery Ligation Market, Europe, 2015 - 2025 (€) 427
  • Figure 9 6: Average Selling Price by Country, Open Surgery Ligation Market, Europe, 2015 - 2025 (US$) 428
  • Figure 9 7: Market Value by Country, Open Surgery Ligation Market, Europe, 2015 - 2025 (€M) 429
  • Figure 9 8: Market Value by Country, Open Surgery Ligation Market, Europe, 2015 - 2025 (US$M) 430
  • Figure 9 9: Laparoscopic Ligation Market, Europe, 2015 - 2025 432
  • Figure 9 10: Units Sold by Country, Laparoscopic Ligation Market, Europe, 2015 - 2025 434
  • Figure 9 11: Average Selling Price by Country, Laparoscopic Ligation Market, Europe, 2015 - 2025 (€) 435
  • Figure 9 12: Average Selling Price by Country, Laparoscopic Ligation Market, Europe, 2015 - 2025 (US$) 436
  • Figure 9 13: Market Value by Country, Laparoscopic Ligation Market, Europe, 2015 - 2025 (€M) 437
  • Figure 9 14: Market Value by Country, Laparoscopic Ligation Market, Europe, 2015 - 2025 (US$M) 438
  • Figure 9 15: Drivers and Limiters, Ligating Clip Applier Market, Europe, 2018 440
  • Figure 9 16: Leading Competitors, Ligating Clip Applier Market, Europe, 2018 442
  • Figure 10 1: Skin Closure Strip Market, Europe, 2015 - 2025 446
  • Figure 10 2: Units Sold by Country, Skin Closure Strip Market, Europe, 2015 - 2025 448
  • Figure 10 3: Average Selling Price by Country, Skin Closure Strip Market, Europe, 2015 - 2025 (€) 449
  • Figure 10 4: Average Selling Price by Country, Skin Closure Strip Market, Europe, 2015 - 2025 (US$) 450
  • Figure 10 5: Market Value by Country, Skin Closure Strip Market, Europe, 2015 - 2025 (€M) 451
  • Figure 10 6: Market Value by Country, Skin Closure Strip Market, Europe, 2015 - 2025 (US$M) 452
  • Figure 10 7: Drivers and Limiters, Skin Closure Strip Market, Europe, 2018 454
  • Figure 10 8: Leading Competitors, Skin Closure Strip Market, Europe, 2018 455
  • Figure 10 9: Leading Competitors by Country, Skin Closure Strip Market, Europe, 2018 456
  • Figure 11 1: Cyanoacrylate-Based Tissue Adhesive Market, Europe, 2015 - 2025 460
  • Figure 11 2: Units Sold by Country, Cyanoacrylate-Based Tissue Adhesive Market, Europe, 2015 - 2025 462
  • Figure 11 3: Average Selling Price by Country, Cyanoacrylate-Based Tissue Adhesive Market, Europe, 2015 - 2025 (€) 463
  • Figure 11 4: Average Selling Price by Country, Cyanoacrylate-Based Tissue Adhesive Market, Europe, 2015 - 2025 (US$) 464
  • Figure 11 5: Market Value by Country, Cyanoacrylate-Based Tissue Adhesive Market, Europe, 2015 - 2025 (€M) 465
  • Figure 11 6: Market Value by Country, Cyanoacrylate-Based Tissue Adhesive Market, Europe, 2015 - 2025 (US$M) 466
  • Figure 11 7: Drivers and Limiters, Cyanoacrylate-Based Tissue Adhesive Market, Europe, 2018 468
  • Figure 11 8: Leading Competitors, Cyanoacrylate-Based Tissue Adhesive Market, Europe, 2018 470
  • Figure 11 9: Leading Competitors by Country, Cyanoacrylate-Based Tissue Adhesive Market, Europe, 2018 471
  • Figure 12 1: Traditional Wound Dressing Market by Segment, Europe, 2015 - 2025 (€M) 476
  • Figure 12 2: Traditional Wound Dressing Market by Segment, Europe, 2015 - 2025 (US$M) 476
  • Figure 12 3: Bandage Market, Europe, 2015 - 2025 480
  • Figure 12 4: Gauze Market, Europe, 2015 - 2025 482
  • Figure 12 5: Tape Market, Europe, 2015 - 2025 484
  • Figure 12 6: Cotton Market, Europe, 2015 - 2025 486
  • Figure 12 7: Drivers and Limiters, Traditional Wound Dressing Market, Europe, 2018 489
  • Figure 12 8: Leading Competitors, Traditional Wound Dressing Market, Europe, 2018 491
  • Figure 13 1: Compression Bandage Market by Segment, Europe, 2015 - 2025 (€M) 495
  • Figure 13 2: Compression Bandage Market by Segment, Europe, 2015 - 2025 (US$M) 496
  • Figure 13 3: Total Compression Bandage Market, Europe, 2015 - 2025 501
  • Figure 13 4: Units Sold by Country, Total Compression Bandage Market, Europe, 2015 - 2025 503
  • Figure 13 5: Average Selling Price by Country, Total Compression Bandage Market, Europe, 2015 - 2025 (€) 504

For a full list of figures, please contact iData.

目次
Product Code: iDATA_EUOB19_MS

Overall, the orthopedic biomaterials market was valued at €521.2 million in 2018. This is expected to increase over the forecast period at a CAGR of 1.6% to reach €582.3 million in 2025.

The BGS market is expected to retain its market share over the forecast period. The cell therapies segment is expected to grow in key markets, such as Germany and Italy over the forecast period, and since these products are typically used in conjunction with BGS materials like synthetics, this will also drive growth in the BGS market.

MAJOR SEGMENTS COVERED IN THE EUROPEAN ORTHOPEDIC BIOMATERIALS MARKET OVERVIEW 1 MARKET REPORT SUITE

While this report suite contains all applicable market data, each of the markets are also available as stand alone MedCore reports. This allows you to get access to only the specific market segment research that you need. You can view all these included reports and segmentation here:

  • European Orthopedic Biomaterials Market Overview - MedView -Gives an easily accessible view of all orthopedic biomaterials markets and trends, and aggregates the data together for a picture of the total European market.
  • Bone Graft Substitutes Market for Europe 2019 - MedCore - Further segmented into Allograft Bone Graft Substitute, Synthetic Bone Graft Substitute, and Demineralized Bone Graft Substitute Bone Matrix Markets.
  • Hyaluronic Acid Viscosupplementation Market for Europe 2019 - MedCore -This report is segmented by the Single-Injection, Three-Injection, and Five-Injection Markets.
  • Bone Morphogenic Protein Growth Factor Therapy Market for Europe 2019 - MedCore - Bone morphogenetic proteins (BMPs) are growth factors that induce the formation of bone after a fracture.
  • Cartilage Repair Market for Europe 2019 - MedCore - Segmented by Osteochondral Allografts, Meniscal Allografts, Autologous Chondrocyte Implantations, and Osteochondral Autografts.

Buying all of these reports together in this suite package will provide you with substantial discounts from the separate prices. Request Pricing to Learn More

MARKET REPORT DATA TYPES INCLUDED

  • Unit Sales, Average Selling Prices, Market Value & Growth Trends
  • 10 Year Scope
  • Market Drivers & Limiters for Each Segment
  • Competitive Analysis with Market Shares for Each Segment
  • Recent Mergers & Acquisitions
  • Disease Overviews and Demographic Information
  • Company Profiles, Product Portfolios and SWOT for Top Competitors
  • Related Press Releases from Top Competitors

COMPANIES ANALYZED

TABLE OF CONTENTS

TABLE OF CONTENTS I

LIST OF FIGURES XII

LIST OF CHARTS XXVIII

EXECUTIVE SUMMARY 1

EUROPEAN ORTHOPEDIC BIOMATERIALS MARKET OVERVIEW 1

COMPETITIVE ANALYSIS 3

MARKET TRENDS 5

MARKET DEVELOPMENTS 6

PROCEDURE NUMBERS 7

MARKETS INCLUDED 9

KEY REPORT UPDATES 10

VERSION HISTORY 11

RESEARCH METHODOLOGY 12

  • Step 1: Project Initiation & Team Selection 12
  • Step 2: Prepare Data Systems and Perform Secondary Research 15
  • Step 3: Preparation for Interviews & Questionnaire Design 17
  • Step 4: Performing Primary Research 18
  • Step 5: Research Analysis: Establishing Baseline Estimates 20
  • Step 6: Market Forecast and Analysis 21
  • Step 7: Identify Strategic Opportunities 23
  • Step 8: Final Review and Market Release 24
  • Step 9: Customer Feedback and Market Monitoring 25

PRODUCT ASSESSMENT 26

  • 2.1 INTRODUCTION 26
  • 2.2 PRODUCT PORTFOLIOS 27
    • 2.2.1 Bone Graft Substitutes 27
    • 2.2.2 Growth Factors 33
      • 2.2.2.1 Other products 36
    • 2.2.3 Cellular Allografts (Stem Cell) 38
    • 2.2.4 Cell Therapy 42
      • 2.2.4.1 Platelet-Rich Plasma 43
      • 2.2.4.2 Concentrated Bone Marrow Aspirate 44
    • 2.2.5 Hyaluronic Acid Viscosupplementation (HAV) 46
    • 2.2.6 Cartilage Repair 49
  • 2.3 REGULATORY ISSUES AND RECALLS 51
    • 2.3.1 Bone Graft Substitutes 51
      • 2.3.1.1 Allografts 51
      • 2.3.1.1.1 MTF 51
      • 2.3.1.2 DBM 51
      • 2.3.1.2.1 AlloSource 51
      • 2.3.1.2.2 SeaSpine 52
      • 2.3.1.2.3 RTI Surgical 52
      • 2.3.1.3 Synthetics 52
      • 2.3.1.3.1 Abyrx 52
      • 2.3.1.3.2 Zimmer Biomet 53
    • 2.3.2 Growth Factors 53
      • 2.3.2.1.1 Medtronic 53
    • 2.3.3 Cell Therapy 54
      • 2.3.3.1 Bone Marrow Cell Therapy 54
      • 2.3.3.1.1 Argon Medical Devices 54
      • 2.3.3.1.2 Stryker 54
      • 2.3.3.1.3 Teleflex 55
    • 2.3.4 Hyaluronic Acid Viscosupplementation 55
      • 2.3.4.1 Three-injection 55
      • 2.3.4.1.1 Ferring Pharmaceuticals 55
    • 2.3.5 Cartilage Repair 56
      • 2.3.5.1.1 Smith & Nephew 56
      • 2.3.5.1.2 Richard Wolf 56
  • 2.4 CLINICAL TRIALS 57
    • 2.4.1 Bone Graft Substitutes 57
      • 2.4.1.1 Allografts 57
      • 2.4.1.1.1 Providence Medical Technology 57
      • 2.4.1.1.2 The University of Texas Health Science 58
      • 2.4.1.1.3 University of Winchester 58
      • 2.4.1.2 BDM 59
      • 2.4.1.2.1 K2M 59
      • 2.4.1.2.2 Zimmer Biomet 59
      • 2.4.1.3 Synthetics 60
      • 2.4.1.3.1 Baxter 60
      • 2.4.1.3.2 Bonesupport 60
      • 2.4.1.3.3 DePuy Synthes 61
      • 2.4.1.3.4 NuVasive 62
      • 2.4.1.3.5 RTI surgical 62
      • 2.4.1.3.6 Sunstar GUIDOR 63
      • 2.4.1.4 Other materials and comparison 64
      • 2.4.1.4.1 Seoul National University Hospital. 64
      • 2.4.1.4.2 Sewon Cellontech 64
      • 2.4.1.4.3 SurgaColl Technologies Limited 65
      • 2.4.1.4.4 University of Colorado 65
      • 2.4.1.4.5 University of Padova 66
    • 2.4.2 Growth Factors 66
      • 2.4.2.1.1 Bioventus 66
      • 2.4.2.1.2 Cerapedics 67
      • 2.4.2.1.3 CGBio 67
      • 2.4.2.1.4 Isto 68
      • 2.4.2.1.5 Medtronic 68
      • 2.4.2.1.6 NuVasive 70
      • 2.4.2.1.7 Wright 70
      • 2.4.2.1.8 Others 71
    • 2.4.3 Cellular Allografts (Stem Cell) 72
      • 2.4.3.1 Cervical 72
      • 2.4.3.1.1 DePuy Synthes 72
      • 2.4.3.1.2 Virginia Spine Institute 72
      • 2.4.3.2 Lumbar 73
      • 2.4.3.2.1 RTI Surgical 73
      • 2.4.3.2.2 Trinity Stem Cell Institute 73
      • 2.4.3.3 Spinal Cord 74
      • 2.4.3.3.1 AFBMTC 74
      • 2.4.3.3.2 Stem Cells Arabia 74
      • 2.4.3.3.3 Pharmicell 75
      • 2.4.3.4 Knee, Foot, Ankle, Tibial 75
      • 2.4.3.4.1 Medipost 75
      • 2.4.3.4.2 Nantes University Hospital 76
      • 2.4.3.4.3 Royan Institute 76
      • 2.4.3.4.4 Red de Terapia Celular 77
      • 2.4.3.4.5 RTI Surgical 77
      • 2.4.3.4.6 University of Jordan 78
    • 2.4.4 Cell Therapy 78
      • 2.4.4.1 Bone Marrow Cell Therapy 78
      • 2.4.4.1.1 Centre of Postgraduate Medical Education 78
      • 2.4.4.1.2 New York University 79
      • 2.4.4.1.3 Stempeutics Research 80
      • 2.4.4.1.4 Royan Institute 80
      • 2.4.4.1.5 Universidad Autonoma de Madrid 81
      • 2.4.4.1.6 Vericel (Aastrom Bioscience) 81
      • 2.4.4.2 Platelet-Rich Cell Therapy 82
      • 2.4.4.2.1 Assistance Publique Hopitaux De Marseille 82
      • 2.4.4.2.2 Assiut University 82
      • 2.4.4.2.3 Brian Walters 83
      • 2.4.4.2.4 Hospital for Special Surgery 83
      • 2.4.4.2.5 Istituto Ortopedico Rizzoli 84
      • 2.4.4.2.6 Rio de Janeiro State University 84
      • 2.4.4.2.7 Tri-Service General Hospital 85
      • 2.4.4.2.8 University of California 86
      • 2.4.4.3 Others 86
    • 2.4.5 Hyaluronic Acid Viscosupplementation 87
      • 2.4.5.1.1 Anika Therapeutics 87
      • 2.4.5.1.2 Bioventus 88
      • 2.4.5.1.3 Cario University 89
      • 2.4.5.1.4 Ferring Pharmaceuticals 89
      • 2.4.5.1.5 Federal University of Minas Gerais 90
      • 2.4.5.1.6 Fidia Pharma USA Inc. 90
      • 2.4.5.1.7 Istituto Ortopedico Rizzoli 91
      • 2.4.5.1.8 University Hospital 91
      • 2.4.5.1.9 Universidade Nova de Lisboa 92
    • 2.4.6 Cartilage Repair 92
      • 2.4.6.1 Autologous Chondrocyte Implantation 92
      • 2.4.6.1.1 BioGend (Exactech) 92
      • 2.4.6.1.2 Histogenics 93
      • 2.4.6.1.3 ISTO and Zimmer Biomet 93
      • 2.4.6.1.4 Shetty-Kim Research Foundation 94
      • 2.4.6.2 Meniscal Allograft 94
      • 2.4.6.2.1 Orthox 94
      • 2.4.6.3 Microfracture Adjunct 95
      • 2.4.6.3.1 Anika Therapeutics 95
      • 2.4.6.3.2 Aesculap Biologics 95
      • 2.4.6.3.3 Sewon Cellontech 96
      • 2.4.6.3.4 Smith & Nephew 96
      • 2.4.6.4 Osteochondral Allograft 97
      • 2.4.6.4.1 TBF Genie Tissulaire 97
      • 2.4.6.5 Particulated Juvenile Cartilage 97
      • 2.4.6.5.1 Zimmer Biomet 97

EUROPEAN ORTHOPEDIC BIOMATERIALS MARKET OVERVIEW 98

  • 3.1 INTRODUCTION 98
    • 3.1.1 Bone Graft Substitutes 99
    • 3.1.2 Growth Factors 99
    • 3.1.3 Hyaluronic Acid Viscosupplementation 99
    • 3.1.4 Autologous Chondrocyte Implantation 100
    • 3.1.5 Cell Therapies 100
  • 3.2 CURRENCY EXCHANGE RATE 101
  • 3.3 MARKET OVERVIEW 102
  • 3.4 TREND ANALYSIS BY SEGMENT 108
  • 3.5 DRIVERS AND LIMITERS 112
    • 3.5.1 Market Drivers 112
    • 3.5.2 Market Limiters 113
  • 3.6 COMPETITIVE MARKET SHARE ANALYSIS 115
  • 3.7 MERGERS AND ACQUISITIONS 121
  • 3.8 COMPANY PROFILES 123
    • 3.8.1 Anika Therapeutics 123
    • 3.8.2 Bioventus 124
    • 3.8.3 DePuy Synthes 125
    • 3.8.4 Ferring Pharmaceuticals 126
    • 3.8.5 Fidia Pharmaceuticals 127
    • 3.8.6 Genzyme (Sanofi Group) 128
    • 3.8.7 Harvest Technologies (Terumo BCT) 129
    • 3.8.8 Integra LifeSciences 130
    • 3.8.9 Medtronic 131
    • 3.8.10 Musculoskeletal Transplant Foundation (MTF) 133
    • 3.8.11 NuVasive 134
    • 3.8.12 Orthofix 135
    • 3.8.13 RTI Surgical 136
    • 3.8.14 Stryker 137
    • 3.8.15 Vericel Corporation (formerly Aastrom Bioscience) 138
    • 3.8.16 Zimmer Biomet 139
  • 3.9 SWOT ANALYSIS 141
    • 3.9.1 Anika Therapeutics 141
    • 3.9.2 Bioventus 143
    • 3.9.3 DePuy Synthes 145
    • 3.9.4 Ferring Pharmaceuticals 146
    • 3.9.5 Fidia Pharmaceuticals 147
    • 3.9.7 Harvest Technologies (Terumo BCT) 149
    • 3.9.8 Integra LifeSciences 150
    • 3.9.9 Medtronic 151
    • 3.9.10 Musculoskeletal Transplant Foundation (MTF) 152
    • 3.9.11 NuVasive 153
    • 3.9.12 Orthofix 154
    • 3.9.14 Stryker 156
    • 3.9.15 Vericel Corporation (formerly Aastrom Bioscience) 157
    • 3.9.16 Zimmer Biomet 158

COUNTRY PROFILES 160

  • 4.1 INTRODUCTION 160
    • 4.1.1 Population 160
    • 4.1.2 GDP Per Capita 160
    • 4.1.3 Price Index 160
  • 4.2 GERMANY 161
  • 4.3 FRANCE 162
  • 4.4 UNITED KINGDOM 163
  • 4.5 ITALY 164
  • 4.6 SPAIN 165
  • 4.7 BENELUX 166
  • 4.8 SCANDINAVIA 167
  • 4.9 AUSTRIA 168
  • 4.10 SWITZERLAND 169
  • 4.11 PORTUGAL 170

PROCEDURE NUMBERS 171

  • 5.1 INTRODUCTION 171
  • 5.2 PROCEDURES 172
    • 5.2.1 By Material 173
    • 5.2.2 By Indication 176
    • 5.2.3 Units per Procedure by Indication 179
  • 5.3 GROWTH FACTOR BONE GRAFT PROCEDURE NUMBERS 182
  • 5.4 HYALURONIC ACID TREATMENT NUMBERS BY TYPE 185
  • 5.5 CARTILAGE REPAIR PROCEDURE NUMBERS BY TYPE 189

ORTHOPEDIC BONE GRAFT SUBSTITUTE MARKET 192

  • 6.1 INTRODUCTION 192
  • 6.2 MARKET OVERVIEW 193
    • 6.2.1 Orthopedic Bone Graft Substitute Market by Material 193
    • 6.2.2 Orthopedic Bone Graft Substitute Market by Indication 199
  • 6.3 MARKET ANALYSIS AND FORECAST 205
    • 6.3.1 Total Bone Graft Substitute Market 205
    • 6.3.2 Total Allograft Bone Graft Substitute Market 212
      • 6.3.2.1 Total Allograft Spine Market 223
      • 6.3.2.1.1 Allograft Cervical Spine Market 233
      • 6.3.2.1.2 Allograft Thoracolumbar Spine Market 240
      • 6.3.2.2 Allograft Trauma and Reconstruction Market 247
      • 6.3.2.3 Allograft Craniomaxillofacial Market 254
    • 6.3.3 Total Synthetic Bone Graft Substitute Market 261
      • 6.3.3.1 Total Synthetic Spine Market 272
      • 6.3.3.1.1 Synthetic Cervical Spine Market 282
      • 6.3.3.1.2 Synthetic Thoracolumbar Spine Market 289
      • 6.3.3.2 Synthetic Trauma and Reconstruction Market 296
      • 6.3.3.3 Synthetic Craniomaxillofacial Market 303
    • 6.3.4 Total Demineralized Bone Graft Substitute Bone Matrix Market 310
      • 6.3.4.1 Total Demineralized Bone Matrix Spine Market 321
      • 6.3.4.1.1 Demineralized Bone Matrix Cervical Spine Market 331
      • 6.3.4.1.2 Demineralized Bone Matrix Thoracolumbar Spine Market 338
      • 6.3.4.2 Demineralized Bone Matrix Trauma and Reconstruction Market 345
      • 6.3.4.3 Demineralized Bone Matrix Craniomaxillofacial Market 352
  • 6.4 DRIVERS AND LIMITERS 359
    • 6.4.1 Market Drivers 359
    • 6.4.2 Market Limiters 360
  • 6.5 COMPETITIVE MARKET SHARE ANALYSIS 362

HYALURONIC ACID VISCOSUPPLEMENTATION MARKET 367

  • 7.1 INTRODUCTION 367
    • 7.1.1 Benefits of Viscosupplementation 368
    • 7.1.2 Synovial Fluid 368
    • 7.1.3 Product Types 369
  • 7.2 MARKET OVERVIEW 370
  • 7.3 MARKET ANALYSIS AND FORECAST 376
    • 7.3.1 Total Hyaluronic Acid Viscosupplementation Market 376
    • 7.3.2 Single-Injection Hyaluronic Acid Viscosupplementation Market 384
    • 7.3.3 Three-Injection Hyaluronic Acid Viscosupplementation Market 392
    • 7.3.4 Five-Injection Hyaluronic Acid Viscosupplementation Market 400
  • 7.4 DRIVERS AND LIMITERS 408
    • 7.4.1 Market Drivers 408
    • 7.4.2 Market Limiters 409
  • 7.5 COMPETITIVE MARKET SHARE ANALYSIS 411

BONE MORPHOGENETIC PROTEIN GROWTH FACTOR THERAPY MARKET 416

  • 8.1 INTRODUCTION 416
  • 8.2 MARKET ANALYSIS AND FORECAST 417
  • 8.3 DRIVERS AND LIMITERS 425
    • 8.3.1 Market Drivers 425
    • 8.3.2 Market Limiters 425
  • 8.4 COMPETITIVE MARKET SHARE ANALYSIS 427

ORTHOPEDIC CARTILAGE REPAIR MARKET 430

  • 9.1 INTRODUCTION 430
    • 9.1.1 Methods for Cartilage Repair 430
      • 9.1.1.1 Osteochondral Allograft Transfer 430
      • 9.1.1.2 Autologous Chondrocyte Implantation (ACI) 431
      • 9.1.1.3 Meniscal Allograft Transplantation 431
  • 9.2 MARKET OVERVIEW 432
  • 9.3 MARKET ANALYSIS AND FORECAST 437
    • 9.3.1 Osteochondral Allograft Market 437
    • 9.3.2 Meniscal Allograft Market 439
    • 9.3.3 Autologous Chondrocyte Implantation Market 441
    • 9.3.4 Osteochondral Autograft Market 449
  • 9.4 DRIVERS AND LIMITERS 451
    • 9.4.1 Market Drivers 451
    • 9.4.2 Market Limiters 451
  • 9.5 COMPETITIVE MARKET SHARE ANALYSIS 453

APPENDIX I: ORTHOPEDIC CELL THERAPY MARKET 457

  • 10.1 INTRODUCTION 457
  • 10.2 CELL THERAPY TREATMENT NUMBERS 461
    • 10.2.1 Overview by Type 461
  • 10.3 MARKET OVERVIEW 463
  • 10.4 MARKET ANALYSIS AND FORECAST 469
    • 10.4.1 Platelet-Rich Plasma Market 469
    • 10.4.2 Bone Marrow Concentrate Market 476
  • 10.5 DRIVERS AND LIMITERS 483
    • 10.5.1 Market Drivers 483
    • 10.5.2 Market Limiters 484
  • 10.6 COMPETITIVE MARKET SHARE ANALYSIS 486

APPENDIX II: CELLULAR ALLOGRAFT MARKET 489

  • 11.1 INTRODUCTION 489
    • 11.1.1 Lineage 490
      • 11.1.1.1 Human Embryonic Stem Cells (hESCs) 490
      • 11.1.1.2 Mesenchymal Stem Cells (MSCs) 490
      • 11.1.1.3 Other Therapeutic Applications 490

ABBREVIATIONS 491

Back to Top